Ex-drug company CEO Martin Shkreli to speak at Harvard
CAMBRIDGE, Mass. - Controversial former pharmaceutical executive Martin Shkreli is set to speak at Harvard while out on bail awaiting his federal securities fraud trial.
The former CEO of Turing Pharmaceuticals is expected to talk about investing and health care at an event organized by the Harvard Financial Analysts Club. The talk on Wednesday is open to the Harvard community only.
Shkreli drew sharp criticism after his company purchased the rights to a drug used by AIDS and cancer patients to fight parasitic infections and raised its price from less than $17 to $750 per pill.
The 33-year-old New York resident is free on $5 million bail pending his federal securities fraud trial in an unrelated case. He has pleaded not guilty. A judge on Thursday approved his request to travel to Massachusetts.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Amazon posts job listings for new Baton Rouge warehouse
State Capitol's front doors will reopen after three years - but it...
'Cajuneers' using military trucks to collect donations for Florence victims
PSC places scrutiny on electric cooperatives across the state
Detention pond gobbling up land in Gonzales neighborhood